EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ABC Transporters, APOE, CYP46A1, and LRP1 Gene Polymorphisms as Markers of Dementia Development in Patients with Hyperlipidemia

Marta Machowska, Jerzy Leszek, Maja Rączy-Krzemianowska, Beata Tomasiewicz, Magdalena Hurkacz, Małgorzata Rąpała iD, Janusz Piechota, Krystyna Głowacka, Anna Wiela-Hojeńska iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Marta Machowska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Wrocław Medical University, 50-556 Wrocław, Poland. Hauptthemen laut MEDLINE: Hyperlipidemias, Apolipoproteins E, Dementia, Polymorphism, Single Nucleotide. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regional Operational Programme of the Lower Silesian Voivodeship 2014-2020, co-financed by the European Union, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In an aging society, solving problems associated with the diagnosis and treatment of dementia-related diseases represents a serious challenge. The aim of the study was to evaluate the possibility of applying molecular biology methods to test polymorphisms recognized in the global literature as potentially useful in assessing the risk of developing dementia in a group of patients with hyperlipidemia. A sample of 203 patients: 109 diagnosed with both dementia and hyperlipidemia, 94 with hyperlipidemia, and 101 individuals as an allele frequency control group—were genotyped. Additional data about cognitive decline and neuropsychological assessment were collected. Among all the studied polymorphisms, the frequency of the ABCA1 rs2230806 polymorphism differed between the analyzed groups. The GG genotype (p = 0.0002, RR = 3.22, CI = 1.63 ÷ 6.37) and the G allele (p = 0.0007, RR = 1.53, CI = 1.19 ÷ 1.97) were more frequent in patients diagnosed with dementia, specifically in those with Alzheimer’s disease. Furthermore, the GG genotype was more common in individuals with a shorter disease duration and lower scores on the Montreal Cognitive Assessment (MoCA) scale, and consequently, with greater cognitive function deficits during early stages of the diagnostic process. ABCA1 rs2230806 genotyping is a potential marker for the early identification of dementia risk in patients with hyperlipidemia, which supports the validity of exploring options for incorporating diagnostics based on molecular biology methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperlipidemiasApolipoproteins EDementiaPolymorphism, Single NucleotideATP Binding Cassette Transporter 1Low Density Lipoprotein Receptor-Related Protein-1ATP-Binding Cassette TransportersHumansMaleFemaleAgedGenetic Predisposition to DiseaseGenotypeMiddle AgedAllelesGene FrequencyBiomarkersAlzheimer DiseaseAged, 80 and overCase-Control Studies

Stichwörter der Autor:innen

ABCA1ABCB1APOECYP46A1LRPdementiahyperlipidemiamarkerspolymorphism

Substanzen

Apolipoproteins EATP Binding Cassette Transporter 1ABCA1 protein, humanApoE protein, humanLRP1 protein, humanLow Density Lipoprotein Receptor-Related Protein-1BiomarkersATP-Binding Cassette Transporters

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Wrocław Medical University, 50-556 Wrocław, Poland.
  • Department of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland.
  • Clinical Department of Internal Medicine, 4th Military Clinical Hospital with Outpatient Clinic, SP ZOZ, 50-981 Wrocław, Poland.
  • Department of Pediatric Surgery, T. Marciniak Lower Silesian Specialist Hospital, 54-049 Wrocław, Poland.
  • Amplicon Ltd., 54-413 Wrocław, Poland.

ORCID-Profile: Małgorzata Rąpała, Anna Wiela-Hojeńska

Förderung

  • Regional Operational Programme of the Lower Silesian Voivodeship 2014-2020, co-financed by the European Union, European Regional Development Fund

Zitieren

APA

Machowska, M., Leszek, J., Rączy-Krzemianowska, M., Tomasiewicz, B., Hurkacz, M., Rąpała, M., Piechota, J., Głowacka, K., & Wiela-Hojeńska, A. (2025). ABC Transporters, APOE, CYP46A1, and LRP1 Gene Polymorphisms as Markers of Dementia Development in Patients with Hyperlipidemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110759

Vancouver

Machowska M, Leszek J, Rączy-Krzemianowska M, Tomasiewicz B, Hurkacz M, Rąpała M, et al. ABC Transporters, APOE, CYP46A1, and LRP1 Gene Polymorphisms as Markers of Dementia Development in Patients with Hyperlipidemia. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110759

BibTeX
@article{Machowska2025,
  author = {Machowska, Marta and Leszek, Jerzy and Rączy-Krzemianowska, Maja and Tomasiewicz, Beata and Hurkacz, Magdalena and Rąpała, Małgorzata and Piechota, Janusz and Głowacka, Krystyna and Wiela-Hojeńska, Anna},
  title = {ABC Transporters, APOE, CYP46A1, and LRP1 Gene Polymorphisms as Markers of Dementia Development in Patients with Hyperlipidemia},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110759}
}
Kostenlos starten →